References
- Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 1990, 82, 4–6. [PUBMED], [INFOTRIEVE]
- Hanahan, D.; Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86, 353–364. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fontanini, G.; Bigini, D.; Vignati, S.; Basolo, F.; Mussi, A.; Lucchi, M.; Chine, S.; Angeletti, C A.; Harris, A L.; Bevilacqua, G. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J. Pathol. 1995, 177, 57–63. [PUBMED], [INFOTRIEVE]
- Takigawa, N.; Segawa, Y.; Fujimoto, N.; Hotta, K.; Eguchi, K. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer. Anticancer Res. 1998, 18, 1251–1254. [PUBMED], [INFOTRIEVE], [CSA]
- Brattstrom, D.; Bergqvist, M.; Larsson, A.; Holmertz, J.; Hesselius, P.; Rosenberg, L.; Brodin, O.; Wagenius, G. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Anticancer Res. 1998, 18, 1123–1127. [PUBMED], [INFOTRIEVE], [CSA]
- Kido, Y. Vascular endothelial growth factor (VEGF) serum concentration changes during chemotherapy in patients with lung cancer. Kurume Med. J. 2001, 48, 43–47. [PUBMED], [INFOTRIEVE], [CSA]
- Choi, J H.; Kim, H C.; Lim, H Y.; Nam, D K.; Kim, H S.; Yi, J W.; Chun, M.; Oh, Y T.; Kang, S.; Park, K J.; Hwang, S C.; Lee, Y H.; Hahn, M H. Vascular endothelial growth factor in the serum of patients with non- small cell lung cancer: correlation with platelet and leukocyte counts. Lung Cancer 2001, 33, 171–179. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fontanini, G.; Vignati, S.; Boldrini, L.; Chine, S.; Silvestri, V.; Lucchi, M.; Mussi, A.; Angeletti, C A.; Bevilacqua, G. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin. Cancer Res. 1997, 3, 861–865. [PUBMED], [INFOTRIEVE], [CSA]
- Salven, P.; Ruotsalainen, T.; Mattson, K.; Joensuu, H. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int. J. Cancer 1998, 79, 144–146. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Banks, R E.; Forbes, M A.; Kinsey, S E.; Stanley, A.; Ingham, E.; Walters, C.; Selby, P J. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer 1998, 77, 956–964. [PUBMED], [INFOTRIEVE]
- Wartiovaara, U.; Salven, P.; Mikkola, H.; Lassila, R.; Kaukonen, J.; Joukov, V.; Orpana, A.; Ristimaki, A.; Heikinheimo, M.; Joensuu, H.; Alitalo, K.; Palotie, A. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost. 1998, 80, 171–175. [PUBMED], [INFOTRIEVE], [CSA]
- Katoh, O.; Tauchi, H.; Kawaishi, K.; Kimura, A.; Satow, Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 1995, 55, 5687–5692. [PUBMED], [INFOTRIEVE]
- Freeman, M R.; Schneck, F X.; Gagnon, M L.; Corless, C.; Soker, S.; Niknejad, K.; Peoples, G E.; Klagsbrun, M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 1995, 55, 4140–4145. [PUBMED], [INFOTRIEVE]
- Salven, P.; Orpana, A.; Joensuu, H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res. 1999, 5, 487–491. [PUBMED], [INFOTRIEVE], [CSA]
- Verheul, H M.; Hoekman, K.; Luykx-de Bakker, S.; Eekman, C A.; Folman, C C.; Broxterman, H J.; Pinedo, H M. Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res. 1997, 3, 2187–2190. [PUBMED], [INFOTRIEVE], [CSA]
- George, M L.; Eccles, S A.; Tutton, M G.; Abulafi, A M.; Swift, R I. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res. 2000, 6, 3147–3152. [PUBMED], [INFOTRIEVE], [CSA]
- Dirix, L Y.; Vermeulen, P B.; Pawinski, A.; Prove, A.; Benoy, I.; De Pooter, C.; Martin, M.; Van Oosterom, A T. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br. J. Cancer 1997, 76, 238–243. [PUBMED], [INFOTRIEVE]
- Linder, C.; Linder, S.; Munck-Wikland, E.; Strander, H. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma. Anticancer Res. 1998, 18, 2063–2068. [PUBMED], [INFOTRIEVE], [CSA]
- Ueno, K.; Inoue, Y.; Kawaguchi, T.; Hosoe, S.; Kawahara, M. Increasedserum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis. Lung Cancer 2001, 31, 213–219. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Takanami, I.; Tanaka, F.; Hashizume, T.; Kikuchi, K.; Yamamoto, Y.; Yamamoto, T.; Kodaira, S. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur. J. Cancer 1996, 32A, 1504–1509. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Suzuki, M.; Iizasa, T.; Ko, E.; Baba, M.; Saitoh, Y.; Shibuya, K.; Sekine, Y.; Yoshida, S.; Hiroshima, K.; Fujisawa, T. Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer 2002, 35, 29–34. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wen, W.; Moses, M A.; Wiederschain, D.; Arbiser, J L.; Folkman, J. The generation of endostatin is mediated by elastase. Cancer Res. 1999, 59, 6052–6056. [PUBMED], [INFOTRIEVE]
- Feldman, A L.; Alexander, H R., Jr.; Bartlett, D L.; Kranda, K C.; Miller, M S.; Costouros, N G.; Choyke, P L.; Libutti, S K. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Ann. Surg. Oncol. 2001, 8, 741–745. [PUBMED], [INFOTRIEVE], [CSA]
- Ma, L.; Elliott, S N.; Cirino, G.; Buret, A.; Ignarro, L J.; Wallace, J L. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 6470–6475. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tolsma, S S.; Volpert, O V.; Good, D J.; Frazier, W A.; Polverini, P J.; Bouck, N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 1993, 122, 497–511. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tuszynski, G P.; Nicosia, R F. The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays 1996, 18, 71–76. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nathan, F E.; Hernandez, E.; Dunton, C J.; Treat, J.; Switalska, H I.; Joseph, R R.; Tuszynski, G P. Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer 1994, 73, 2853–2858. [PUBMED], [INFOTRIEVE]
- Yamashita, Y.; Kurohiji, T.; Tuszynski, G P.; Sakai, T.; Shirakusa, T. Plasma thrombospondin levels in patients with colorectal carcinoma. Cancer 1998, 82, 632–638. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tuszynski, G P.; Smith, M.; Rothman, V L.; Capuzzi, D M.; Joseph, R R.; Katz, J.; Besa, E C.; Treat, J.; Switalska, H I. Thrombospondin levels in patients with malignancy. Thromb. Haemost. 1992, 67, 607–611. [PUBMED], [INFOTRIEVE]
- Ohta, Y.; Shridhar, V.; Kalemkerian, G P.; Bright, R K.; Watanabe, Y.; Pass, H I. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma. Cancer 1999, 85, 2570–2576. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fontanini, G.; Boldrini, L.; Calcinai, A.; Chine, S.; Lucchi, M.; Mussi, A.; Angeletti, C A.; Basolo, F.; Bevilacqua, G. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density. Clin. Cancer Res. 1999, 5, 155–161. [PUBMED], [INFOTRIEVE], [CSA]
- McLaren, K M. Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. J. Clin. Pathol. 1983, 36, 197–199. [PUBMED], [INFOTRIEVE]